---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-038793"
form_type: "8-K"
ticker: "CORT"
cik: "0001088856"
company_name: "CORCEPT THERAPEUTICS INC"
filed_at: "2026-05-28T20:04:39+00:00"
generated_at: "2026-05-28T21:22:50.262690+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Corcept shareholders approve 8M-share increase to 2024 Incentive Award Plan

## Summary
- Stockholders approved amendment to 2024 Incentive Award Plan, adding 8,000,000 authorized shares.
- All eight director nominees elected; vote totals show majority support for each.
- Ernst & Young ratified as independent auditor for fiscal 2026.
- Advisory vote on named executive officer compensation passed with 72.5 million 'for' votes.

## SEC filing metadata
- accession: 0001628280-26-038793
- form_type: 8-K
- ticker: CORT
- cik: 0001088856
- company_name: CORCEPT THERAPEUTICS INC
- filed_at: 2026-05-28T20:04:39+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1088856/000162828026038793/0001628280-26-038793-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1088856/000162828026038793/cort-20260521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-038793
- JSON: https://secwatch.observer/filing/0001628280-26-038793.json
- Plain text: https://secwatch.observer/filing/0001628280-26-038793.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.